Biochips Market is projected to expand at a steady CAGR over the forecast period 2017
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Biochips</strong> <strong>Market</strong> <strong>is</strong> <strong>projected</strong> <strong>to</strong> <strong>expand</strong> <strong>at</strong><br />
a <strong>steady</strong> <strong>CAGR</strong> <strong>over</strong> <strong>the</strong> <strong>forecast</strong> <strong>period</strong><br />
<strong>2017</strong>-2025<br />
The L<strong>at</strong>est Comprehensive Industry research study titled, “<strong>Biochips</strong> <strong>Market</strong> by<br />
Products, Applic<strong>at</strong>ion - Global Industry Analys<strong>is</strong> and Forecast To 2025” publ<strong>is</strong>hed<br />
by Crystal <strong>Market</strong> Research, st<strong>at</strong>es th<strong>at</strong> <strong>the</strong> ferment<strong>at</strong>ion chemicals market <strong>is</strong><br />
<strong>projected</strong> <strong>to</strong> be around $ 26 billion by 2025.<br />
The biochips market <strong>is</strong> expected <strong>to</strong> be around $26 billion by 2025. Increasing<br />
advancements in personalized medicine, r<strong>is</strong>ing demand for mini<strong>at</strong>uriz<strong>at</strong>ion of clinical and<br />
biological test systems, increase in research activities rel<strong>at</strong>ed <strong>to</strong> proteomics and genomics,<br />
advancements in designing protein arrays and r<strong>is</strong>ing applic<strong>at</strong>ions of biochips in<br />
acceler<strong>at</strong>ed drug development are some of <strong>the</strong> major fac<strong>to</strong>rs driving <strong>the</strong> growth of global<br />
biochips market. More<strong>over</strong>, increase in <strong>the</strong> incidence of chronic d<strong>is</strong>eases such as cancer<br />
has prompted development of biochips <strong>to</strong> be used for diagnosing certain variants of <strong>the</strong>se<br />
d<strong>is</strong>eases and for controlling d<strong>is</strong>ease progression. According <strong>to</strong> <strong>the</strong> N<strong>at</strong>ional Cancer<br />
Institute under <strong>the</strong> U.S. Department of Health and Human Services, between 2012 and<br />
2030, new cancer cases around <strong>the</strong> world are expected <strong>to</strong> increase by 50% from 14<br />
million <strong>to</strong> 21 million. With such high incidence of cancer, <strong>the</strong> rel<strong>at</strong>ed research efforts are<br />
expected <strong>to</strong> significantly increase thus favorably contributing <strong>to</strong> <strong>the</strong> growth of biochips<br />
market during <strong>the</strong> <strong>forecast</strong> <strong>period</strong>. However, fac<strong>to</strong>rs such as high cost of biochip<br />
instrument<strong>at</strong>ion and unclear regula<strong>to</strong>ry guidelines can hamper <strong>the</strong> growth of th<strong>is</strong> biochips<br />
market during <strong>the</strong> <strong>forecast</strong> <strong>period</strong>.<br />
Get sample copy of th<strong>is</strong> Report: https://www.crystalmarketresearch.com/reportsample/SE09229<br />
Key <strong>Market</strong> Players:<br />
<br />
<br />
<br />
<br />
Thermo F<strong>is</strong>her Scientific Inc<br />
Illumina Inc<br />
PerkinElmer Inc<br />
Agilent Technologies Inc.<br />
1 | P a g e
Fluidigm Corpor<strong>at</strong>ion<br />
General Electric Company<br />
Bio-Rad Labora<strong>to</strong>ries Inc.<br />
bioMérieux SA<br />
Cellix Ltd.<br />
DNA chips segment domin<strong>at</strong>ed <strong>the</strong> global biochips market in 2016. Th<strong>is</strong> market<br />
dominance can be <strong>at</strong>tributed <strong>to</strong> <strong>the</strong> extensive adoption of DNA chips for detection and<br />
diagnos<strong>is</strong> of various genetic d<strong>is</strong>eases along with increased focus on research rel<strong>at</strong>ed <strong>to</strong><br />
next-gener<strong>at</strong>ion sequencing and genomics. With rapid adoption of diagnostic lab-on-a-chip<br />
(LOAC) and DNA analys<strong>is</strong> for point-of-care diagnostics and drug d<strong>is</strong>c<strong>over</strong>y applic<strong>at</strong>ions,<br />
<strong>the</strong> global biochips market will experience robust growth during <strong>the</strong> <strong>forecast</strong> <strong>period</strong>. Drug<br />
d<strong>is</strong>c<strong>over</strong>y and development segment held a major share of <strong>the</strong> biochips market in 2016 as<br />
biochips are being increasingly adopted for developing highly specific drug molecules and<br />
new chemical entity (NCE) drugs for <strong>the</strong> tre<strong>at</strong>ment of various d<strong>is</strong>eases. <strong>Biochips</strong> can<br />
considerably reduce <strong>the</strong> cost of drug d<strong>is</strong>c<strong>over</strong>y and aid in improving drug safety and hence<br />
are being widely adopted by biotechnology and pharmaceutical companies for drug<br />
d<strong>is</strong>c<strong>over</strong>y applic<strong>at</strong>ions.<br />
Two major technologies used for fabric<strong>at</strong>ing biochips involve microarrays and<br />
microfluidics. A microarray <strong>is</strong> a silicon chip or a glass slide which cons<strong>is</strong>ts of an array of<br />
molecules such as polypeptides, clones, oligonucleotides and antibodies. These molecules<br />
used are primarily used for gene expression and simultaneous examin<strong>at</strong>ion of rel<strong>at</strong>ionship<br />
between different genes. Microfluidics <strong>is</strong> a technology which involves micro-channels<br />
segmented on glass or a silicon substr<strong>at</strong>e. Th<strong>is</strong> technology has various biomedical<br />
applic<strong>at</strong>ions th<strong>at</strong> include immunoassays, drug d<strong>is</strong>c<strong>over</strong>y, capillary electrophores<strong>is</strong> and cell<br />
biology research.<br />
Make Inquiry about Report: https://www.crystalmarketresearch.com/send-anenquiry/SE09229<br />
<strong>Market</strong> Opportunities<br />
With high prevalence of cancer and o<strong>the</strong>r chronic d<strong>is</strong>eases worldwide, <strong>the</strong> need for<br />
advanced drug development altern<strong>at</strong>ives <strong>is</strong> increasing significantly in all parts of <strong>the</strong><br />
world. Emerging markets such as Asia-Pacific are expected <strong>to</strong> offer significant growth<br />
opportunities for <strong>the</strong> global biochips market in coming years as expenditure on advanced<br />
research <strong>is</strong> r<strong>is</strong>ing considerably in developing countries such as China and India.<br />
<strong>Biochips</strong> <strong>Market</strong> Segment<strong>at</strong>ion:<br />
By Product:<br />
<br />
<br />
<br />
<br />
<br />
DNA Chips<br />
Protein Chips<br />
Lab-on-a-chip<br />
T<strong>is</strong>sue Arrays<br />
Cell Arrays<br />
2 | P a g e
By Applic<strong>at</strong>ion:<br />
Gene Expression<br />
Genomics<br />
SNP Genotyping<br />
Drug D<strong>is</strong>c<strong>over</strong>y & Development<br />
Clinical Diagnostics<br />
Cancer Diagnos<strong>is</strong> & Tre<strong>at</strong>ment<br />
Proteomics<br />
Agricultural Biotechnology<br />
IVD and POC<br />
High-Throughput Screening<br />
By Fabric<strong>at</strong>ion Technology:<br />
<br />
<br />
Microfluidics<br />
Microarrays<br />
By End User:<br />
<br />
<br />
<br />
Academic & Research Institutes<br />
Hospitals and Diagnostics Centers<br />
Biotechnology and Pharmaceutical Companies<br />
Get Cus<strong>to</strong>mized Report and Best D<strong>is</strong>count offers for your region:<br />
https://www.crystalmarketresearch.com/cus<strong>to</strong>miz<strong>at</strong>ion/SE09229<br />
About Crystal <strong>Market</strong> Research:<br />
Crystal <strong>Market</strong> Research <strong>is</strong> a U.S. based market research and business intelligence<br />
company. Crystal offers one s<strong>to</strong>p solution for market research, business intelligence, and<br />
consulting services <strong>to</strong> help clients make more informed dec<strong>is</strong>ions. It provides both<br />
syndic<strong>at</strong>ed as well as cus<strong>to</strong>mized research studies for its cus<strong>to</strong>mers spread across <strong>the</strong><br />
globe. The company offers market intelligence reports across a broad range of industries<br />
including healthcare, chemicals & m<strong>at</strong>erials, technology, au<strong>to</strong>motive, and energy.<br />
Contact Us:<br />
Judy<br />
304 South Jones Blvd, Suite 1896,<br />
Las Vegas NV 89107,<br />
United St<strong>at</strong>es<br />
Toll Free: +1-888-213-4282<br />
Email: sales@crystalmarketresearch.com<br />
Blog: blog.crystalmarketresearch.com<br />
Website: www.crystalmarketresearch.com<br />
3 | P a g e
Change language